Korean J Pediatr Gastroenterol Nutr.
2005 Mar;8(1):70-75.
Topical Tacrolimus Resulting in a Marked Resolution of Perianal Crohn's Disease
- Affiliations
-
- 1Department of Pediatrics, Keimyung University School of Medicine, Daegu, Korea. pedgi@korea.com
Abstract
- Crohn's disease of the perineum is notably resistant to treatment. We describe our experiences of tacrolimus ointment application in three patients with intractable perianal Crohn's disease. At the time of diagnosis patients showed anal fissure with ulcer, anal fistula, or perianal abscess, respectively. These lesions did not respond to steroid, metronidazole, mesalazine, or azathioprine, though the pediatric Crohn's disease activity index was markedly improved during the treatment period (4 to 12 months). Topical tacrolimus was applied and resulted in marked healing and a rapid granulation of cavity edges within 6 weeks to 3 months. Topical tacrolimus at a low dose shows a promise for the management of childhood perianal Crohn's disease. Further controlled studies are required to assess the efficacy and safety of this treatment.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Surgical treatment of perianal fistula in Crohn's disease
- A Case of Crohn's Disease Showing a Skin Lesion with a Cobblestone-like Appearance in the Perianal Region
- Two Cases of Pyoderma Gangrenosum Associated with Crohn's Disease
- Three Cases of Oral Lichen Planus Treated with Topical Tacrolimus
- Four Cases of Atopic Dermatitis with Topical Tacrolimus Therapy
